Remark Holdings Inc (MARK)
$1.44 0.19 (11.66%)
18:24 EDT MARK Stock Quote Delayed 30 Minutes
Previous Close $1.44
Market Cap 48.04M
PE Ratio -0.29
Volume (Avg. Vol.) 11.69M
Day's Range 1.36 - 1.65
52-Week Range 0.25 - 3.56
Dividend & Yield N/A (N/A)
MARK Stock Predictions, Articles, and Remark Holdings Inc News
- From InvestorPlace
- From the Web
With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy to capitalize on this trend.
As a way to capitalize on state-of-the-art coronavirus scanning technology, MARK stock gets high marks as the company continues to innovate.
Political winds have changed favorably for MARK stock, particularly Remark’s AI-powered surveillance business. However, it ultimately remains a gamble.
Remark's AI solutions, services contracts, and a potential Sharecare IPO provide a solid growth platform for MARK Stock
FB, AVGO and MARk all have plenty of growth left in the tank as they stand to benefit from major shifts in society over the next few years.
Remark's technology has many valuable applications and has been validated. As a result, investors should buy MARK stock.
Remark has promising technology that could help slow the spread of Covid-19. However, its weak balance sheet is a major sticking point.
While there are plenty of bargains on the market again due to the recent pullback, T, MCD, MARK, GOOGL and FB look like the best stocks to buy now to upgrade your portfolio.
Remark has ownership interest in the privately-held Sharecare. In case of an IPO by Sharecare, MARK stock is likely to hit new highs.
By Thomas Niel
MARK stock looks at first glance to be a great way to play current trends. But, given hype is what's driving shares, skip it for now.
On June 1, Remark announced that the company’s partnership with Hanvon won the phase two implementation of the smart stores for China Mobile. The contract is said to be worth several million dollars, although no specific numbers were given.
Remark's innovative technologies are already having an impact during the Covid-19 pandemic, but it's entering a crowded field. Is MARK stock a buy today?
While there's certainly a speculative element to buying MARK stock, the firm looks like a good long-term play in a post-pandemic world.
By Joel Baglole
MARK stock provides exposure to the fast growing artificial intelligence segment, but the company's financial performance remains a concern.
You could do a lot worse than MARK, but as a riskier investment it’s also apparent investors can make any speculations much more sound using this leveraged strategy.
With its superb, useful technology and access to a "hot" IPO, MARK stock is worth a shot.
The relisting of MARK stock on the NASDAQ exchange is one of several reasons to consider a position in the shares.
From The Motley Fool
From Market News Video
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Teladoc Health Inc (TDOC), where a total of 14,205 contracts have traded so far, representing approximately 1.4 million underlying shares. That amounts to about 50.2% of TDOC's average daily trading volume over the past month of 2.8 million shares..
From Market News Video
From Simply Wall St
A look at the shareholders of Inseego Corp. (NASDAQ:INSG) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see<div><a class="permalink" href="https://simplywall.st/stocks/us/tech/nasdaq-insg/inseego/news/what-type-of-shareholders-make-up-inseego-corp-s-nasdaqinsg-share-registry/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader